相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
K. Oberg et al.
ANNALS OF ONCOLOGY (2020)
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
Paymaneh D. Malihi et al.
CLINICAL CANCER RESEARCH (2020)
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
Francesca M. Rizzo et al.
BRITISH JOURNAL OF CANCER (2019)
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
Michaela Bowden et al.
ONCOTARGET (2017)
Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms
Mohid S. Khan et al.
CLINICAL CANCER RESEARCH (2016)
Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms
Irvin M. Modlin et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Expression of somatostatin receptors 2 and 5 in lecirculating tumour cells from patients with neuroendocrine tumours
Alexa Childs et al.
BRITISH JOURNAL OF CANCER (2016)
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
I. M. Modlin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)aEuro
E. Grande et al.
ANNALS OF ONCOLOGY (2015)
Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status
Mark Kidd et al.
ENDOCRINE-RELATED CANCER (2015)
Consensus on biomarkers for neuroendocrine tumour disease
Kjell Oberg et al.
LANCET ONCOLOGY (2015)
Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
Mohid S. Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
Thomas Walter et al.
EUROPEAN JOURNAL OF CANCER (2012)
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2012)
Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors
Mohid S. Khan et al.
CLINICAL CANCER RESEARCH (2011)
Chromogranin A-Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Irvin M. Modlin et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Dermot O'Toole et al.
NEUROENDOCRINOLOGY (2009)
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Ulrich-Frank Pape et al.
CANCER (2008)
Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
Sara Ekeblad et al.
CLINICAL CANCER RESEARCH (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Chromogranin A levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours
G. C. Nikou et al.
PANCREATOLOGY (2008)
Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program
Matthew J. Hayat et al.
ONCOLOGIST (2007)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours
D Nehar et al.
CLINICAL ENDOCRINOLOGY (2004)
分享论文
